Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Charles River Laboratories Intl (NY: CRL ) 227.62 +9.38 (+4.30%) Official Closing Price Updated: 7:00 PM EDT, Jul 22, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 453,030 Open 222.46 Bid (Size) 218.00 (1) Ask (Size) 230.60 (1) Prev. Close 218.24 Today's Range 217.68 - 228.44 52wk Range 161.65 - 275.00 Shares Outstanding 50,396,622 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Charles River Laboratories Schedules Second-Quarter 2024 Earnings Release and Conference Call July 16, 2024 From Charles River Laboratories International, Inc. Via Business Wire Apple To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Wednesday July 10, 2024 Via Benzinga Performance YTD -2.83% -2.83% 1 Month +8.47% +8.47% 3 Month -2.12% -2.12% 6 Month +5.47% +5.47% 1 Year +9.83% +9.83% More News Read More Charles River to Perform Plasmid Manufacturing for AAVantgarde July 08, 2024 From Charles River Laboratories International, Inc. Via Business Wire These Nike Analysts Are No Longer Bullish; Here Are Top 5 Downgrades For Friday June 28, 2024 Via Benzinga Demystifying Charles River: Insights From 4 Analyst Reviews June 28, 2024 Via Benzinga The Analyst Verdict: Charles River In The Eyes Of 4 Experts June 06, 2024 Via Benzinga Charles River Laboratories Announces Strategic Lentiviral Vector Manufacturing Collaboration with Gates Institute at University of Colorado Anschutz Medical Campus June 25, 2024 From Charles River Laboratories International, Inc. Via Business Wire Charles River and Captain T Cell Announce Plasmid DNA and Viral Vector Manufacturing Alliance for Gene-Modified Cell Therapy June 17, 2024 From Charles River Laboratories International, Inc. Via Business Wire Charles River Laboratories, in Collaboration With MatTek Corporation, Awarded Grant from the Foundation for Chemistry Research and Initiatives to Advance Research Alternatives June 11, 2024 From Charles River Laboratories International, Inc. Via Business Wire The Analyst Landscape: 7 Takes On Charles River May 10, 2024 Via Benzinga Charles River Laboratories Expands Access to CRADL® Contract Vivarium Space in Somerville June 06, 2024 From Charles River Laboratories International, Inc. Via Business Wire Charles River Laboratories Announces Development of Nonclinical Virtual Control Groups with Sanofi to Reduce the Use of Animals in Research June 04, 2024 From Charles River Laboratories International, Inc. Via Business Wire Charles River Laboratories to Present at William Blair and Jefferies Conferences June 03, 2024 From Charles River Laboratories International, Inc. Via Business Wire Charles River Launches Viral Vector Tech Transfer Program to Safeguard Gene Therapy Development May 30, 2024 From Charles River Laboratories International, Inc. Via Business Wire CRL Stock Earnings: Charles River Beats EPS, Beats Revenue for Q1 2024 May 09, 2024 Via InvestorPlace Charles River Laboratories Announces First-Quarter 2024 Results May 09, 2024 From Charles River Laboratories International, Inc. Via Business Wire The 7 Best Growth Stocks to Buy in May 2024 May 08, 2024 Via InvestorPlace 10 Health Care Stocks With Whale Alerts In Today's Session May 07, 2024 Via Benzinga Charles River Launches Viral Vector Reference Materials to Streamline the Transition to GMP May 02, 2024 From Charles River Laboratories International, Inc. Via Business Wire Charles River Laboratories Achieves 100% Renewable Electricity Usage Globally April 22, 2024 From Charles River Laboratories International, Inc. Via Business Wire Charles River Laboratories Launches Alternative Methods Advancement Project to Reduce Reliance on Animal Testing April 16, 2024 From Charles River Laboratories International, Inc. Via Business Wire Charles River Laboratories Schedules First-Quarter 2024 Earnings Release and Conference Call April 12, 2024 From Charles River Laboratories International, Inc. Via Business Wire Charles River and Deciphex Launch Patholytix Foresight, a Transformative AI-Powered Decision Support Tool for Toxicologic Pathology April 11, 2024 From Charles River Laboratories International, Inc. Via Business Wire Charles River Announces Rare Disease Gene Therapy Collaboration with Axovia Therapeutics April 09, 2024 From Charles River Laboratories International, Inc. Via Business Wire Charles River to Perform Plasmid Production for Ship of Theseus April 04, 2024 From Charles River Laboratories International, Inc. Via Business Wire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.